Yoshikazu Harada

Dr. Yoshikazu Harada

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2021 in BMC Public Health
Verified
Journal Article
Open access
PDF file
YHYoshikazu Harada
Yoshikazu Harada
TNTomohisa Nagata
Tomohisa Nagata
MNMasako Nagata
Masako Nagata
AHArisa Harada
Arisa Harada
RORyoichi Oya
Ryoichi Oya
KMKoji Mori
Koji Mori
Background: This study aimed to examine the association between overtime work and the frequency of preventive dental visits among workers in Japan.Methods: A self-administered questionnaire was completed by 14,847 daytime-workers. We used a logistic regression model stratified by sex and age and adjusted for marital status, occupation, education, and oral status to investigate the association between overtime work hours and the frequency of preventive dental visits.Results: In total 1037 men (9.3%) and 511 women (13.9%) attended quarterly preventive dental visits, and 2672 men (23.9%) and 1165 women (31.8%) attended annual preventive dental visits. Overtime work was statistically significantly associated with quarterly preventive dental visits among men aged 50–59 years, with adjusted odds ratios (aOR) and 95% confidence intervals (CI) of 0.73 (0.56–0.95), 0.75 (0.54–1.04), and 0.55 (0.34–0.90) for < 20, 20–39, and ≥40 h overtime/month, respectively. No such trends were observed for men aged < 50 years and women of all ages. Overtime work of < 20, 20–40, and ≥40 h overtime/month was statistically significantly associated with annual preventive dental visits among men aged 40–49 years (aOR [95%CI]: 0.76 [0.61–0.95], 0.84 [0.65–1.09], and 0.72 [0.51–1.00], respectively) and 50–59 years (aOR [95%CI]: 0.75 [0.61–0.91], 0.76 [0.59–0.97], and 0.63 [0.45–0.88], respectively). No such trends were observed in men < 40 years and women of all ages.Conclusions: Our study revealed associations between overtime and preventive dental visits among male workers aged in their 40s and 50s.

10 February 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
HHHiroshi Harada
Hiroshi Harada
THToru Hachisuga
Toru Hachisuga
YHYoshikazu Harada
Yoshikazu Harada
MSMami Shibahara
Mami Shibahara
MMMidori Murakami
Midori Murakami
KYKiyoshi Yoshino
Kiyoshi Yoshino
Background: The immunoreactive (IR) subtype is one of the subtypes of high-grade serous ovarian carcinoma (HGSOC) with intra-tumoral lymphocytic infiltration. A positive prognostic correlation between IR subtype and R0 + optimal surgery has been reported. This study investigates the prognostic significance of tumor-infiltrating lymphocytes (TILs) in the suboptimal surgery group of HGSOCs. Methods: After reviewing 318 malignant ovarian tumors detected in our database between 2000 and 2017, 74 HGSOCs with supplemental p53 immunostaining were selected. Differences in progression-free survival (PFS) and overall survival (OS) between the two groups of the IR subtype and the other subtypes were investigated. Based on pathological findings, HGSOCs were divided into two groups: those with or without abundant TILs. Results: Abundant TILs were detected in 17 cases of HGSOC (22.9%). Clinicopathological characteristics including age, CA125, FIGO stage, and residual disease did not show significant differences between the two groups. Lymph node metastasis was more common in the IR subtype group (p = 0.04). In the suboptimal surgery group, the 5-year PFS and OS (Kaplan–Meier estimates) in cases with (n = 10) or without (n = 21) abundant TILs were 10% and 0% (p = 0.097) and 70% and 28.5% (p = 0.012), respectively. The median time (range) to OS in cases with or without abundant TILs were 58 (34–81) months and 39 (22–55) months, respectively. Multivariate analysis in OS showed significant differences in TILs. Conclusions: Abundant intra-tumoral lymphocytic infiltration is an independent and favorable prognostic indicator for the suboptimal surgery group in HGSOCs and is associated with treatment response via cancer immunity.

6 December 2025 in Cancers
Verified
Journal Article
Open access
PDF file
MSMami Shibahara
Mami Shibahara
HHHiroshi Harada
Hiroshi Harada
T栗Tomoko 栗田
Tomoko 栗田
MMMidori Murakami
Midori Murakami
YHYoshikazu Harada
Yoshikazu Harada
KYKiyoshi Yoshino
Kiyoshi Yoshino
Background/Objectives: Tumour-infiltrating lymphocytes (TILs) significantly influence the prognosis of epithelial ovarian cancer (EOC). Advanced EOCs often cause neutrophilia, ascites, and malnutrition. The neutrophil-to-lymphocyte ratio (NLR) serves as a marker of systemic inflammation. This study investigated the prognostic significance of pre-treatment NLR and TILs in advanced EOCs. Methods: Overall, 101 advanced EOCs (stages III–IV, FIGO 2014) were treated between 2005 and 2020. Based on pathological findings, advanced EOCs were classified as having high or low TILs using CD8 and CD4 immunostaining. The tumour proportion score was calculated to determine PD-L1 expression. The number of marker-positive cells was counted using HALO. Progression-free survival and overall survival (OS) were compared between the high- and low-NLR groups based on TILs levels. Results: Clinicopathological characteristics, including age, FIGO stage, histological subtype, and postoperative residual disease, did not significantly differ among the four groups defined by NLR and intra-epithelial CD8+ TILs (CD8+ iTILs). Multivariate analysis of OS revealed that NLR and CD8+ iTILs were independent prognostic factors, and no correlation was observed between them. The 5-year OS rates were 82.2% in the low NLR–high CD8+ iTILs group (n = 25), 41.7% in the low NLR–low CD8+ iTILs group (n = 16), 47.2% in the high NLR–high CD8+ iTILs group (n = 34), and 26.0% in the high NLR–low CD8+ iTILs group (n = 26). In the low-NLR subgroup, OS was significantly prolonged in the high CD8+ iTILs group (p = 0.023). Conclusions: In advanced EOCs, the status of tumour-localised immunity and pre-treatment systemic inflammation influenced long-term prognosis.

1 January 1994 in The journal of the Japanese Practical Surgeon Society
Verified
Journal Article
Open access
YSYuhichiroh Shirohzu
Yuhichiroh Shirohzu
TTTakaho Tanaka
Takaho Tanaka
YHYoshikazu Harada
Yoshikazu Harada
NINobuya Ishibashi
Nobuya Ishibashi
NUNobuharu Uchida
Nobuharu Uchida
TKTeruo Kakegawa
Teruo Kakegawa

4 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MSMami Shibahara
Mami Shibahara
HHHiroshi Harada
Hiroshi Harada
T栗Tomoko 栗田
Tomoko 栗田
MMMidori Murakami
Midori Murakami
YHYoshikazu Harada
Yoshikazu Harada
KYKiyoshi Yoshino
Kiyoshi Yoshino
Background/Objectives: Tumour-infiltrating lymphocytes (TILs) significantly influence the prognosis of epithelial ovarian cancer (EOC). Advanced EOCs often cause neutrophilia, ascites, and malnutrition. The neutrophil-to-lymphocyte ratio (NLR) serves as a marker of systemic inflammation. This study investigated the prognostic significance of pre-treatment NLR and TILs in advanced EOCs. Methods: Overall, 101 advanced EOCs (stages III–IV, FIGO 2014) were treated between 2005 and 2020. Based on pathological findings, advanced EOCs were classified as having high or low TIL density using CD8 immunostaining. The number of marker-positive cells was counted using HALO. Progression-free survival and overall survival (OS) were compared between the high- and low-NLR groups based on CD8+ TIL levels. Results: Clinicopathological characteristics, including age, FIGO stage, histological subtype, and postoperative residual disease, did not significantly differ among the four groups defined by NLR and intra-epithelial CD8+ TILs (CD8+ iTILs). Multivariate Cox regression analysis of OS revealed that NLR and CD8+ iTILs were independent prognostic factors. The 5-year OS rates (Kaplan–Meier estimates) were 82.2% (median survival time not reached; range, 8–163 months) in the low NLR–high CD8+ iTIL group (n=25); 41.7% (46 months ; range, 2–109 months) in the low NLR–low CD8+ iTIL group (n=16); 47.2% (52 months; range, 1–181 months) in the high NLR–high CD8+ iTIL group (n=34); and 26.0% (24 months, 2–106 months) in the high NLR–low CD8+ iTIL group (n=26) (p<0.001). Conclusions: In advanced EOCs, the status of tumour-localised immunity and pre-treatment systemic inflammation influenced long-term prognosis.

27 December 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
HHHiroshi Harada
Hiroshi Harada
THToru Hachisuga
Toru Hachisuga
YHYoshikazu Harada
Yoshikazu Harada
MSMami Shibahara
Mami Shibahara
MMMidori Murakami
Midori Murakami
KYKiyoshi Yoshino
Kiyoshi Yoshino
Background: Immunoreactive (IR) subtype is one of the subtypes of high-grade serous ovarian carcinoma (HGSOC) with intra-tumoral lymphocytic infiltration. A positive prognostic correlation between IR subtype and R0 + optimal surgery has been reported. This study investigates the prognostic significance of the tumor-infiltrating lymphocytes (TILs) in the suboptimal surgery group of HGSOCs. Methods: After reviewing 318 malignant ovarian tumors detected in our database between 2000 and 2017, 74 HGSOCs with supplemental p53 immunostaining were selected. Differences in progression-free survival (PFS) and overall survival (OS) between the 2 groups of the IR subtype and the other subtypes were investigated. Based on pathological findings, HGSOCs were divided into 2 groups: those with or without abundant TILs. Results: Abundant TILs were detected in 17 cases of HGSOC (22.9%). Clinicopathological characteristics including age, CA125, FIGO stage, and residual disease did not show significant differences between the 2 groups. Lymph node metastasis was more common in the IR subtype group (p=0.04). In the suboptimal surgery group, the 5-year PFS and OS (Kaplan-Meier estimates) in cases with (n=10) or without (n=21) abundant TILs were 10% and 0% (P=0.097) and 70% and 28.5% (P=0.012), respectively. The median time (range) to OS in cases with or without abundant TILs were 58 (34-81) months and 39 (22-55) months, respectively. Multivariate analysis in OS showed significant differences in TILs. Conclusions: Abundant intra-tumoral lymphocytic infiltration is an independent and favorable prognostic indicator for the suboptimal surgery group in HGSOCs, and is associated with treatment response via cancer immunity.